CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
关于老挝专利「CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER」，老商通整理了如下公开信息，由 OXFORD BIOTHERAPEUTICS LTD 于 2014-10-10 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/421，DIP 编号 LAP421，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2025-10-03。国际分类 / IPC 标注为 A61K 39/00、A61K 47/48、C07K 16/28、C07K 16/30。发明人 / 设计人包括 ACKROYD, James Edward、TERRETT, Jonathan Alexander。代理机构 / 代理人记载为 Lao Trademark Agency。公开摘要提示：The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and me…。
This Laos patent “CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER” is a public DIP intellectual-property record, filed by OXFORD BIOTHERAPEUTICS LTD on 2014-10-10; current status: Awaiting formal examination. Identifiers include application No. P/421; DIP id LAP421; protection kind Patent - PCT National Phase. Key dates: publication 2025-10-03. Classification: A61K 39/00、A61K 47/48、C07K 16/28、C07K 16/30. Inventor(s)/designer(s): ACKROYD, James Edward, TERRETT, Jonathan Alexander. Abstract hint: The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and me…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ສິດທິບັດ «CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ OXFORD BIOTHERAPEUTICS LTD ໃນວັນທີ 2014-10-10; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/421; ລະຫັດ DIP LAP421; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2025-10-03. ປະເພດ/ຫ້ອງ: A61K 39/00、A61K 47/48、C07K 16/28、C07K 16/30. ນັກປະດິດ/ນັກອອກແບບ: ACKROYD, James Edward, TERRETT, Jonathan Alexander. ສະຫຼຸບ: The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and me…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/421
图样
基础信息
- 类型
- 专利
- 申请号
P/421- 状态
- 等待形式审查
- 申请人
- OXFORD BIOTHERAPEUTICS LTD
- 代理机构
- Lao Trademark Agency
- 申请日期
- 2014-10-10
- 公开/公告日
- 2025-10-03
- 国际分类
- A61K 39/00 · A61K 47/48 · C07K 16/28 · C07K 16/30
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including pancreatic cancer, ovarian cancer, breast cancer, colorectal cancer, esophageal cancer, skin cancer, thyroid cancer, lung cancer, multiple myeloma and lymphoma.
The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including pancreatic cancer, ovarian cancer, breast cancer, colorectal cancer, esophageal cancer, skin cancer, thyroid cancer, lung cancer, multiple myeloma and lymphoma.